Loading the session
Loading the session
Loading instrument
$367.79
+3.92%Market closedDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:30 IST · A quote does not mean the product is available to trade on your account.
In brief
Questions investors ask
Quotes run fifteen minutes behind.
Closed at $367.79 on 4 Nov 2026: 0.9% below the 52-week high of $371.00 (28 Oct 2026) and 50.4% above the low of $244.52 (7 Nov 2025).
Daily price bars, split-adjusted · as of 4 Nov 2026
1 month: +18.0% (SPY −1.6%, XLV +13.5%). 3 months: +17.1% (SPY −0.4%, XLV +15.5%). 1 year: +45.8% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: LH, SPY and XLV · as of 4 Nov 2026
The 4 Nov 2026 gain of 3.9% was 3.4× its average daily move of 1.2% over the past year, and its largest one-day gain since 28 Oct 2026.
Daily closes, split-adjusted · as of 4 Nov 2026
The 4 Nov 2026 close of $367.79 was 13.3% above its 50-day average ($324.50) and 27.3% above its 200-day average ($288.88). It has closed above the 200-day for 92 sessions, since 26 Jun 2026. The 50-day average crossed above the 200-day on 23 Jul 2026, 73 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
The 14-session relative strength index closed at 72.8 on 4 Nov 2026, its 1st session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026
Price return, split-adjusted
At the 4 Nov 2026 close
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
October 28, 2026
+8.78%July 24, 2025
+6.86%August 1, 2024
+8.33%